|
HBIO Harvard Bioscience Inc 1123494 |
| Balance Sheet |
|
Current Assets
|
$47,479,000.00 |
|
Assets
|
$77,938,000.00 |
|
Current Liabilities
|
$23,863,000.00 |
|
Liabilities
|
$67,892,000.00 |
|
Equity
|
$10,046,000.00 |
|
Shares Out
|
4510182.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-662,000.00 |
|
Investing Cash Flow
|
$-620,000.00 |
| Market Analysis |
Market Cap
|
$27,467,008.38 |
|
Price
|
$6.06 |
|
BVPS
|
2.23 |
|
PB
|
2.73 |
|
EPS
|
-0.77 |
|
PS
|
0.33 |
|
FCF
|
$-1,088,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:42 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
0.00 |
|
|
2026-05-12 |
-0.33 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.01 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
0.00 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view HBIO documents filed with the SEC.
HBIO Filings
Clear
